Mather Group »

Anika Therapeutics shares owned by Mather Group

Quarter-by-quarter ownership of Anika Therapeutics (ANIK) shares owned by Mather Group from 13F filings

Historical chart of Mather Group investment in Anika Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Anika Therapeutics held by Mather Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Anika Therapeutics by Mather Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $940 100 9.40
2025-03-31 $1.5k 100 15.03

More positions owned by Mather Group

Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Schwab Strategic Tr Us Lcap Va Etf (SCHV)
Vanguard Intl Equity Index F Ftse Europe Etf (VGK)
Lennox International (LII)
Vanguard Intl Equity Index F Ftse Pacific Etf (VPL)
Dimensional Etf Trust Emgr Cre Eqt Mng (DFAE)
Vanguard Scottsdale Fds Mtg-bkd Secs Etf (VMBS)
Spdr Series Trust Portfli Intrmdit (SPTI)
Vanguard Bd Index Fds Intermed Term (BIV)
Vanguard Index Fds Growth Etf (VUG)
Vanguard Index Fds Value Etf (VTV)
Dimensional Etf Trust Intl Small Cap V (DISV)
Dimensional Etf Trust Us Small Cap Val (DFSV)
Vanguard Scottsdale Fds Shrt Trm Corp Bd (VCSH)
Spdr Series Trust Portfolio Ln Tsr (SPTL)

View all positions for Mather Group

Top funds holding Anika Therapeutics

BlackRock
Trigran Investments
Caligan Partners
Vanguard Group
Acadian Asset Management
Dimensional Fund Advisors
Capital Management Corporation
Boothbay Fund Management
Renaissance Technologies
Geode Capital Management
State Street Corporation
D. E. Shaw & Co
Envestnet Asset Management
Northern Trust
Jacobs Levy Equity Management

View all funds holding Anika Therapeutics